Researchers at the Johns Hopkins Kimmel Cancer Center have made significant progress toward development of a simple, noninvasive liquid biopsy test that detects prostate cancer from RNA and other specific metabolic chemicals ...
Feb 28, 2020
0
329
A drug used to treat enlarged prostate may also be able to slow the progression of Parkinson's disease.
Sep 16, 2019
0
131
The prostates of older mice contain more luminal progenitor cells—cells capable of generating new prostate tissue—than the prostates of younger mice, UCLA researchers have discovered.
Aug 06, 2019
0
42
New research from Michigan State University indicates that embryonic tissue, key to the development of a baby's gender, could contribute to an enlarged prostate, or BPH, in men later in life.
Mar 13, 2017
0
2
Prostate gland enlargement can cause uncomfortable urinary symptoms for men. And, as they age, their risk increases. Approximately 30% of men experience symptoms by age 60 and 50% of men by the time they are 80.
Jul 05, 2022
0
9
Does having an enlarged prostate doom you to prostate cancer?
Aug 25, 2021
0
12
In the last decade, concerns have emerged around finasteride, a drug used for treating male-pattern baldness and prostate gland enlargement. Organizations such as the Post-Finasteride Syndrome Foundation have warned about ...
Nov 11, 2020
0
74
A novel MRI-guided procedure that uses therapeutic ultrasound effectively treats prostate cancer with minimal side effects, according to a new study presented today at the annual meeting of the Radiological Society of North ...
Dec 02, 2019
0
50
epidur下接受关节置换的患者al anesthesia have no increased risk for postoperative adverse genitourinary (GU) complications by skipping preoperative indwelling urinary catheters, according to a study ...
Oct 03, 2019
0
1
(HealthDay)—Marijuana use is associated with both sperm functional defects and an increased risk for being on a lower urinary tract symptom (LUTS) medication among men with benign prostatic hyperplasia (BPH)/LUTS, according ...
May 06, 2019
0
2
Benign prostatic hyperplasia(BPH) also known asbenign prostatic hypertrophy(technically a misnomer),benign enlargement of the prostate (BEP), andadenofibromyomatous hyperplasia, refers to the increase in size of the prostate.
Properly, BPH involves hyperplasia rather than hypertrophy, but the nomenclature is often interchangeable, even amongst urologists. It involves hyperplasia of prostatic stromal and epithelial cells, resulting in the formation of large, fairly discrete nodules in the periurethral region of the prostate. When sufficiently large, the nodules compress the urethral canal to cause partial, or sometimes virtually complete, obstruction of the urethra, which interferes with the normal flow of urine. It leads to symptoms of urinary hesitancy, frequent urination, dysuria (painful urination), increased risk of urinary tract infections, and urinary retention. Although prostate specific antigen levels may be elevated in these patients because of increased organ volume and inflammation due to urinary tract infections, BPH is not considered to be a premalignant lesion.
Adenomatous prostatic growth is believed to begin at approximately age 30 years. An estimated 50% of men have histologic evidence of BPH by age 50 years and 75% by age 80 years. In 40-50% of these patients, BPH becomes clinically significant.
